Acebutolol
- TRADE NAME: Sectral (Sanofi-Aventis)
- INDICATIONS: Hypertension, angina, ventricular arrhythmias
- CLASS: Antiarrhythmic class II, Beta adrenergic blocker, Beta blocker
- HALF-LIFE: 3–7 hours
ACE inhibitors, Adrenergic neurone blockers, Alcohol, Aldesleukin, Alpha blockers, Alprostadil, Amiodarone, Angiotensin II receptor antagonists, Antiarrhythmics, Antidiabetics, Anxiolytics and hypnotics, Baclofen, Calcium channel blockers, Cardiac glycosides, Clonidine, Corticosteroids, Diazoxide, Diltiazem, Disopyramide, Diuretics, Ergotamine, Estrogens, Flecainide, General anesthetics, Hydralazine, Insulin, Levodopa, MAO inhibitors, Mefloquine, Methyldopa, Methysergide, Minoxidil, Moxisylyte, Moxonidine, Nifedipine, Nitrates, Nitroprusside, NSAIDs, Phenothiazines, Pilocarpine, Prazosin, Tizanidine, Verapamil
PREGNANCY CATEGORY: B
Contraindicated in persistently severe bradycardia, second- and third-degree heart
block, overt cardiac failure, and cardiogenic shock.
Cutaneous side effects of beta-receptor blockers are clinically polymorphous. They apparently appear after several months of continuous therapy.
Please login to see the rest of this drug profile
Page last updated 08/22/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
